ARVN
Arvinas Inc
Price:  
7.44 
USD
Volume:  
2,147,622.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas Relative Valuation

-257.9%
Upside

As of 2025-06-21, the Relative Valuation of Arvinas Inc (ARVN) is (11.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.44 USD, the upside of Arvinas Inc based on Relative Valuation is -257.9%.

The range of the Relative Valuation is (11.44) - (11.39) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.4x - 17.8x 17.6x
Forward P/E multiples 17.9x - 20.0x 19.2x
Fair Price (11.44) - (11.39) (11.75)
Upside -253.8% - -253.1% -257.9%
7.44 USD
Stock Price
(11.75) USD
Fair Price

Arvinas Relative Valuation - Historical P/E Data

Date P/E
2025-06-20 -11.65
2025-06-18 -11.70
2025-06-17 -11.72
2025-06-16 -11.54
2025-06-13 -11.58
2025-06-12 -11.86
2025-06-11 -12.01
2025-06-10 -12.25
2025-06-09 -12.26
2025-06-06 -11.79
2025-06-05 -10.84
2025-06-04 -10.89
2025-06-03 -10.96
2025-06-02 -11.48
2025-05-30 -11.28
2025-05-29 -11.75
2025-05-28 -11.41
2025-05-27 -10.48
2025-05-23 -10.20
2025-05-22 -10.13
2025-05-21 -9.79
2025-05-20 -10.40
2025-05-19 -10.23
2025-05-16 -10.17
2025-05-15 -9.81
2025-05-14 -9.51
2025-05-13 -9.85
2025-05-12 -10.21
2025-05-09 -10.35
2025-05-08 -10.67
2025-05-07 -10.45
2025-05-06 -10.89
2025-05-05 -11.95
2025-05-02 -12.09
2025-05-01 -11.32
2025-04-30 -15.07
2025-04-29 -14.68
2025-04-28 -14.43
2025-04-25 -14.18
2025-04-24 -14.32
2025-04-23 -14.21
2025-04-22 -14.00
2025-04-21 -13.71
2025-04-17 -13.47
2025-04-16 -11.98
2025-04-15 -11.87
2025-04-14 -11.59
2025-04-11 -10.89
2025-04-10 -10.37
2025-04-09 -10.54